Clinical Trial Update: PRP in ACLR to Prevent PTOA [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating platelet-rich plasma (PRP) in anterior cruciate ligament reconstruction to prevent post-traumatic osteoarthritis and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Injury
• Post-traumatic Osteoarthritis

Drugs mentioned

• Platelet-rich plasma (PRP)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Anterior Cruciate Ligament Injuries, Post-traumatic Osteoarthritis | Phase 3 | Status: RECRUITING